You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 82 No. 5, May 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sulfadimethoxine Use in Chronic Urinary Drainage

HERBERT SOHN, M.D.; LESTER PERSKY, M.D.

AMA Arch Surg. 1961;82(5):719-722.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The problem of maintaining prolonged urinary drainage in patients with spinal-cord injuries has for many years taxed the best efforts of urologists and others interested in rehabilitation. Much has been written about the best forms of drainage, use of prophylactic antibacterials, diets, and fluids. Calculus formation, pyelonephritis, and sepsis, in general, all occur at a high incidence rate.1 Sulfonamides have been extensively used in treating and preventing bladder infections since the advent of chemotherapy. Recently, long-acting sulfonamides have come into prominence in efforts to prevent the growth of urinary bacteria. One of these, sulfadimethoxine, which has been widely used for the treatment of upper respiratory infections,2,7 is also useful in the treatment of soft-tissue8 and urologic infections.7,11

Chemically, sulfadimethoxine* is 2,4-dimethoxy-6-sulfanilamido-1,3-diazine with the structural formula seen in the Figure. It is a colorless, odorless, tasteless, crystalline material which melts at 200 to 202 C. The drug . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

Formerly, Crile Veterans Administration Hospital, and now associated with the Strauss Surgical Group, Chicago (Dr. Sohn); Director, Department of Urology, University Hospitals, Cleveland, and Crile Veterans Administration Hospital, and Associate Professor of Urology, Western Reserve University, Cleveland, Ohio (Dr. Persky).


Footnotes

Received for publication Dec. 27, 1960.

This study was carried out under the auspices of the Crile Veterans Administration Hospital, Cleveland, Ohio.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.